Drug Enforcement Administration – Federal Register Recent Federal Regulation Documents

Results 1,901 - 1,950 of 4,460
Christina B. Paylan, M.D.; Decision and Order
Document Number: 2015-28727
Type: Notice
Date: 2015-11-12
Agency: Drug Enforcement Administration, Department of Justice
Perry County Food & Drug Decision and Order
Document Number: 2015-28723
Type: Notice
Date: 2015-11-12
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Placement of Eluxadoline Into Schedule IV
Document Number: 2015-28718
Type: Rule
Date: 2015-11-12
Agency: Drug Enforcement Administration, Department of Justice
With the issuance of this final rule, the Administrator of the Drug Enforcement Administration places the substance 5-[[[(2S)-2-amino- 3-[4-aminocarbonyl)-2,6-dimethylphenyl]-1-oxopropyl][(1S)-1-( 4-phenyl- 1H-imidazol-2-yl)ethyl]amino]methyl]-2-methoxybenzoic acid (eluxadoline), including its salts, isomers, and salts of isomers, into schedule IV of the Controlled Substances Act. This scheduling action is pursuant to the Controlled Substances Act which requires that such actions be made on the record after opportunity for a hearing through formal rulemaking. This action imposes the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule IV controlled substances on persons who handle (manufacture, distribute, dispense, import, export, engage in research, conduct instructional activities, or possess) or propose to handle eluxadoline.
Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Vicks® VapoInhaler®
Document Number: 2015-27266
Type: Rule
Date: 2015-10-27
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is amending the table of Excluded Nonnarcotic Products to update the listing for Vicks[supreg] VapoInhaler[supreg], containing 50 mg levmetamfetamine in a nasal decongestant inhaler, marketed by The Proctor & Gamble Company. This over-the-counter, non-narcotic drug product is excluded from provisions of the Controlled Substances Act.
Schedules of Controlled Substances: Table of Excluded Nonnarcotic Products: Nasal Decongestant Inhaler/Vapor Inhaler
Document Number: 2015-27264
Type: Rule
Date: 2015-10-27
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration is amending the table of Excluded Nonnarcotic Products to update the company name for the drug product Nasal Decongestant Inhaler/Vapor Inhaler (containing 50 milligrams levmetamfetamine) to Aphena Pharma SolutionsNew York, LLC. This over-the-counter, nonnarcotic drug product is excluded from the provisions of the Controlled Substances Act.
Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals, Inc.
Document Number: 2015-26682
Type: Notice
Date: 2015-10-21
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Halo Pharmaceutical, Inc.
Document Number: 2015-26675
Type: Notice
Date: 2015-10-21
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Cerilliant Corporation
Document Number: 2015-26674
Type: Notice
Date: 2015-10-21
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Cody Laboratories, Inc.
Document Number: 2015-26670
Type: Notice
Date: 2015-10-21
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Cambrex Charles City
Document Number: 2015-26669
Type: Notice
Date: 2015-10-21
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Sigma-Aldrich International GMBH-Sigma Aldrich Co LLC
Document Number: 2015-26668
Type: Notice
Date: 2015-10-21
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chemicals, Inc.
Document Number: 2015-25882
Type: Notice
Date: 2015-10-13
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Registration: Unither Manufacturing, LLC
Document Number: 2015-25881
Type: Notice
Date: 2015-10-13
Agency: Drug Enforcement Administration, Department of Justice
Unither Manufacturing, LLC applied to be registered as an importer of a certain basic class of controlled substance. The Drug Enforcement Administration (DEA) grants Unither Manufacturing, LLC registration as an importer of this controlled substance.
Bulk Manufacturer of Controlled Substances Application: Apertus Pharmaceuticals
Document Number: 2015-25880
Type: Notice
Date: 2015-10-13
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Lab
Document Number: 2015-25879
Type: Notice
Date: 2015-10-13
Agency: Drug Enforcement Administration, Department of Justice
Established Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2016
Document Number: 2015-25373
Type: Notice
Date: 2015-10-06
Agency: Drug Enforcement Administration, Department of Justice
This final order establishes the initial 2016 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA) and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation
Document Number: 2015-24748
Type: Notice
Date: 2015-09-30
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances Registration: Noramco, Inc.
Document Number: 2015-24747
Type: Notice
Date: 2015-09-30
Agency: Drug Enforcement Administration, Department of Justice
Noramco, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Noramco, Inc. registration as a manufacturer of those controlled substances.
James Alvin Chaney, M.D.: Decision and Order
Document Number: 2015-24128
Type: Notice
Date: 2015-09-23
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Cedarburg Pharmaceuticals, Inc.
Document Number: 2015-24127
Type: Notice
Date: 2015-09-23
Agency: Drug Enforcement Administration, Department of Justice
Brown's Discount Apothecary, BC, Inc., and Bolling Apothecary, Inc.
Document Number: 2015-24126
Type: Notice
Date: 2015-09-23
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Mallinckrodt LLC
Document Number: 2015-24125
Type: Notice
Date: 2015-09-23
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Euticals, Inc.
Document Number: 2015-24124
Type: Notice
Date: 2015-09-23
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
Document Number: 2015-24123
Type: Notice
Date: 2015-09-23
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances Registration: AMRI Rensselaer Inc.
Document Number: 2015-24122
Type: Notice
Date: 2015-09-23
Agency: Drug Enforcement Administration, Department of Justice
AMRI Rensselaer, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants AMRI Rensselaer, Inc. registration as a manufacturer of those controlled substances.
Importer of Controlled Substances Registration: Fisher Clinical Services, Inc.
Document Number: 2015-24121
Type: Notice
Date: 2015-09-23
Agency: Drug Enforcement Administration, Department of Justice
Fisher Clinical Services, Inc. applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Fisher Clinical Services, Inc. registration as an importer of those controlled substances.
Importer of Controlled Substances Registration: Wildlife Laboratories, Inc.
Document Number: 2015-24120
Type: Notice
Date: 2015-09-23
Agency: Drug Enforcement Administration, Department of Justice
Wildlife Laboratories, Inc., applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Wildlife Laboratories, Inc. registration as an importer of those controlled substances.
Importer of Controlled Substances Registration: Rhodes Technologies
Document Number: 2015-24119
Type: Notice
Date: 2015-09-23
Agency: Drug Enforcement Administration, Department of Justice
Rhodes Technologies applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Rhodes Technologies registration as an importer of those controlled substances.
Importer of Controlled Substances Application: Fresenius Kabi USA, LLC
Document Number: 2015-24118
Type: Notice
Date: 2015-09-23
Agency: Drug Enforcement Administration, Department of Justice
Chung-Kuang Chen, M.D.; Dismissal of Proceeding
Document Number: 2015-23599
Type: Notice
Date: 2015-09-21
Agency: Drug Enforcement Administration, Department of Justice
Final Adjusted Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2015
Document Number: 2015-23199
Type: Notice
Date: 2015-09-16
Agency: Drug Enforcement Administration, Department of Justice
This final order establishes the final adjusted 2015 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Schedules of Controlled Substances: Temporary Placement of the Synthetic Cannabinoid MAB-CHMINACA Into Schedule I
Document Number: 2015-23198
Type: Proposed Rule
Date: 2015-09-16
Agency: Drug Enforcement Administration, Department of Justice
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to temporarily schedule the synthetic cannabinoid N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide (common names, MAB- CHMINACA and ADB-CHMINACA) into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act. This action is based on a finding by the Administrator that the placement of this synthetic cannabinoid into schedule I of the Controlled Substances Act is necessary to avoid an imminent hazard to the public safety. Any final order will impose the administrative, civil, and criminal sanctions and regulatory controls applicable to schedule I controlled substances under the Controlled Substances Act on the manufacture, distribution, possession, importation, exportation, research, and conduct of instructional activities of this synthetic cannabinoid.
Masters Pharmaceuticals, Inc.; Decision and Order
Document Number: 2015-23038
Type: Notice
Date: 2015-09-15
Agency: Drug Enforcement Administration, Department of Justice
Agency Information Collection Activities: Request for Comments
Document Number: 2015-22642
Type: Notice
Date: 2015-09-09
Agency: Farm Service Agency, Drug Enforcement Administration
We (the U.S. Geological Survey) will ask the Office of Management and Budget (OMB) to approve the information collection (IC) described below. As required by the Paperwork Reduction Act (PRA) of 1995, and as part of our continuing efforts to reduce paperwork and respondent burden, we invite the general public and other Federal agencies to take this opportunity to comment on this IC.
Agency Information Collection Activities: Request for Comments
Document Number: 2015-20125
Type: Notice
Date: 2015-08-14
Agency: Farm Service Agency, Drug Enforcement Administration
We (the U.S. Geological Survey) will ask the Office of Management and Budget (OMB) to approve the information collection (IC) described below. As required by the Paperwork Reduction Act (PRA) of 1995, and as part of our continuing efforts to reduce paperwork and respondent burden, we invite the general public and other Federal agencies to take this opportunity to comment on this IC.
Agency Information Collection Activities: Request for Comments
Document Number: 2015-19730
Type: Notice
Date: 2015-08-12
Agency: Farm Service Agency, Drug Enforcement Administration
To comply with the Paperwork Reduction Act of 1995 (PRA), the U.S. Geological Survey (USGS) is inviting comments on an information collection request (ICR) that we have sent to the Office of Management and Budget (OMB) for review and approval. The ICR concerns the paperwork requirements for the National Land Remote Sensing Education, Outreach and Research Activity (NLRSEORA) and describes the nature of the collection and the estimated burden and cost. As required by the PRA, and as part of our continuing efforts to reduce paperwork and respondent burden, we invite the general public and other Federal agencies to take this opportunity to comment on this ICR. This Information Collection is scheduled to expire on September 30, 2015.
National Earthquake Prediction Evaluation Council
Document Number: 2015-18645
Type: Notice
Date: 2015-07-30
Agency: Farm Service Agency, Drug Enforcement Administration
Pursuant to Public Law 106-503, the National Earthquake Prediction Evaluation Council (NEPEC) will hold its next meeting at the Southern Methodist University in Dallas, Texas. The Committee is comprised of members from academia, industry, and State government. The Committee shall advise the Director of the U.S. Geological Survey (USGS) on matters relating to the USGS's participation in the National Earthquake Hazards Reduction Program. At the meeting, the Council will receive briefings and updates on: The USGS's strategic plan for operational earthquake forecasting and outcomes of a user-needs workshop on that subject held in March 2015; on USGS work to calculate the probability of future earthquakes in areas of the U.S. subject to induced seismicity; on the estimation of aftershock probabilities and on new modeled estimates of earthquake likelihood along the Wasatch fault zone by a technical working group; and on development of a plan for rapid communication of earthquake information in the Cascadia region. The NEPEC will review USGS procedures for calculating and communicating aftershock probabilities following large earthquakes in areas outside of California and the application of these procedures following the M7.8 Gorkha, Nepal earthquake of April 2015. The council will also finalize a statement for public release summarizing the proper procedures for posing and testing earthquake predictions and forecasts. Meetings of the National Earthquake Prediction Evaluation Council are open to the public. A draft meeting agenda is available upon request from the Executive Secretary on request (contact information below). In order to ensure sufficient seating and hand-outs, it is requested that visitors pre-register by September 13. Members of the public wishing to make a statement to the Council should provide notice of that intention by August 26 so that time may be allotted in the agenda. A meeting summary will be posted by September 30 to the committee Web site: https://earthquake.usgs.gov/aboutus/nepec/.
Agency Information Collection Activities: Request for Comments on the National Ground-Water Monitoring Network Cooperative Funding Program
Document Number: 2015-17835
Type: Notice
Date: 2015-07-21
Agency: Farm Service Agency, Drug Enforcement Administration
We (the U.S. Geological Survey) are notifying the public that we have submitted to the Office of Management and Budget (OMB) the information collection request (ICR) described below. To comply with the Paperwork Reduction Act of 1995 (PRA) and as part of our continuing efforts to reduce paperwork and respondent burden, we invite the general public and other Federal agencies to take this opportunity to comment on this ICR.
National Earthquake Prediction Evaluation Council
Document Number: 2015-17641
Type: Notice
Date: 2015-07-20
Agency: Farm Service Agency, Drug Enforcement Administration
Pursuant to Public Law 106-503, the National Earthquake Prediction Evaluation Council (NEPEC) will hold its next meeting at the Southern Methodist University in Dallas, Texas. The Committee is comprised of members from academia, industry, and State government. The Committee shall advise the Director of the U.S. Geological Survey (USGS) on matters relating to the USGS's participation in the National Earthquake Hazards Reduction Program. At the meeting, the Council will receive briefings and updates on: The USGS's strategic plan for operational earthquake forecasting and outcomes of a user-needs workshop on that subject held in March 2015; on USGS work to calculate the probability of future earthquakes in areas of the U.S. subject to induced seismicity; on the estimation of aftershock probabilities and on new modeled estimates of earthquake likelihood along the Wasatch fault zone by a technical working group; and on development of a plan for rapid communication of earthquake information in the Cascadia region. The NEPEC will review USGS procedures for calculating and communicating aftershock probabilities following large earthquakes in areas outside of California and the application of these procedures following the M7.8 Gorkha, Nepal earthquake of April 2015. The council will also finalize a statement for public release summarizing the proper procedures for posing and testing earthquake predictions and forecasts. Meetings of the National Earthquake Prediction Evaluation Council are open to the public. A draft meeting agenda is available upon request from the Executive Secretary on request (contact information below). In order to ensure sufficient seating and hand-outs, it is requested that visitors pre-register by September 13. Members of the public wishing to make a statement to the Council should provide notice of that intention by August 26 so that time may be allotted in the agenda. A meeting summary will be posted by September 30 to the committee Web site: https://earthquake.usgs.gov/aboutus/nepec/.
Odette L. Campbell, M.D.; Decision and Order
Document Number: 2015-17310
Type: Notice
Date: 2015-07-14
Agency: Drug Enforcement Administration, Department of Justice
Trenton F. Horst, D.O.; Decision and Order
Document Number: 2015-17309
Type: Notice
Date: 2015-07-14
Agency: Drug Enforcement Administration, Department of Justice
Proposed Adjustments to the Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2015
Document Number: 2015-16699
Type: Notice
Date: 2015-07-08
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration proposes to adjust the 2015 aggregate production quotas for several controlled substances in schedules I and II of the Controlled Substances Act and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Manufacturer of Controlled Substances Registration: Rhodes Technologies
Document Number: 2015-16458
Type: Notice
Date: 2015-07-06
Agency: Drug Enforcement Administration, Department of Justice
Rhodes Technologies applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Rhodes Technologies registration as a manufacturer of those controlled substances.
Manufacturer of Controlled Substances Registration: Halo Pharmaceutical, Inc.
Document Number: 2015-16456
Type: Notice
Date: 2015-07-06
Agency: Drug Enforcement Administration, Department of Justice
Halo Pharmaceutical, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Halo Pharmaceutical, Inc. registration as a manufacturer of those controlled substances.
Manufacturer of Controlled Substances Registration: Noramco, Inc.
Document Number: 2015-16455
Type: Notice
Date: 2015-07-06
Agency: Drug Enforcement Administration, Department of Justice
Noramco, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Noramco, Inc. registration as a manufacturer of those controlled substances.
Manufacturer of Controlled Substances Registration: Euticals, Inc.
Document Number: 2015-16454
Type: Notice
Date: 2015-07-06
Agency: Drug Enforcement Administration, Department of Justice
Euticals, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Euticals, Inc. registration as a manufacturer of those controlled substances.
Importer of Controlled Substances Registration: Mylan Pharmaceuticals, Inc.
Document Number: 2015-16453
Type: Notice
Date: 2015-07-06
Agency: Drug Enforcement Administration, Department of Justice
Mylan Pharmaceuticals, Inc. applied to be registered as an importer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Mylan Pharmaceuticals, Inc. registration as an importer of those controlled substances.
Manufacturer of Controlled Substances Registration: Johnson Matthey, Inc.
Document Number: 2015-16452
Type: Notice
Date: 2015-07-06
Agency: Drug Enforcement Administration, Department of Justice
Johnson Matthey, Inc. applied to be registered as a manufacturer of certain basic classes of controlled substances. The Drug Enforcement Administration (DEA) grants Johnson Matthey, Inc. registration as a manufacturer of those controlled substances.
Importer of Controlled Substances Application: Lipomed, Inc.
Document Number: 2015-16448
Type: Notice
Date: 2015-07-06
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: United States Pharmacopeial Convention
Document Number: 2015-16445
Type: Notice
Date: 2015-07-06
Agency: Drug Enforcement Administration, Department of Justice
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.